Related references
Note: Only part of the references are listed.The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Elias Campo et al.
BLOOD (2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita Alaggio et al.
LEUKEMIA (2022)
Molecular biology of Hodgkin lymphoma
Marc A. Weniger et al.
LEUKEMIA (2021)
Genomic Landscape of Hodgkin Lymphoma
Magdalena M. Brune et al.
CANCERS (2021)
A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics
Hassan Awada et al.
CELLS (2021)
Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma
Ann-Kathrin Desch et al.
LEUKEMIA (2020)
Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma
Ying Liu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Genomic characterization of diffuse large B-cell lymphoma transformation of nodular lymphocyte-predominant Hodgkin lymphoma
Joo Y. Song et al.
LEUKEMIA (2020)
A 2020 Vision Into Hodgkin Lymphoma Biology
Stephanie N. Hurwitz et al.
ADVANCES IN ANATOMIC PATHOLOGY (2020)
Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma-A Unique Entity A Report of Two Cases With Low-Level Bone Marrow Involvement and Review of the Literature
Sharon Koorse Germans et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)
Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma
Nadine Abdallah et al.
CLINICAL CANCER RESEARCH (2020)
Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma
Stefania Pittaluga et al.
BLOOD CANCER DISCOVERY (2020)
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Brian A. Walker et al.
LEUKEMIA (2019)
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients
Artur Jurczyszyn et al.
LEUKEMIA & LYMPHOMA (2019)
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
Sven Borchmann et al.
BLOOD (2019)
Molecular signatures of multiple myeloma progression through single cell RNA-Seq
Jin Sung Jang et al.
BLOOD CANCER JOURNAL (2019)
Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion
Kirsty Wienand et al.
BLOOD ADVANCES (2019)
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma
Enrico Tiacci et al.
BLOOD (2018)
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
Valeria Spina et al.
BLOOD (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Bjoern Chapuy et al.
NATURE MEDICINE (2018)
Global Burden of Multiple Myeloma ASystematic Analysis for the Global Burden of Disease Study 2016
Andrew J. Cowan et al.
JAMA ONCOLOGY (2018)
Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways
Benoit Tessoulin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Lenalidomide and secondary acute lymphoblastic leukemia: a case series
Marisela Tan et al.
HEMATOLOGICAL ONCOLOGY (2017)
Genomic complexity of multiple myeloma and its clinical implications
Salomon Manier et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma
S. Hartmann et al.
LEUKEMIA (2016)
Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma
Sylvia Hartmann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells
Jonathan Reichel et al.
BLOOD (2015)
Chromosome 8q24.1/c-MYC abnormality: a marker for high-risk myeloma
Isabella C. Glitza et al.
LEUKEMIA & LYMPHOMA (2015)
Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy
George Mulligan et al.
BLOOD (2014)
Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma - Endpoints of a Spectrum of One Disease?
Sylvia Hartmann et al.
PLOS ONE (2013)
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
John S. Welch et al.
CELL (2012)
Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide
Yawara Kawano et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols
S. Z. Usmani et al.
LEUKEMIA (2012)
Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network
A. Smith et al.
BRITISH JOURNAL OF CANCER (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
Nodular, Lymphocyte-Predominant Hodgkin Lymphoma A Long-Term Study and Analysis of Transformation to Diffuse Large B-Cell Lymphoma in a Cohort of 164 Patients From the Adult Lymphoma Study Group
Irene Biasoli et al.
CANCER (2010)
Mutations in the genes coding for the NF-kappa B regulating factors I kappa B alpha and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma
Martin A. Schumacher et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Transformation to Aggressive Lymphoma in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma
Mubarak Al-Mansour et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
R. Fonseca et al.
LEUKEMIA (2009)
Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis
Verena Brune et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Genetic aberrations and survival in plasma cell leukemia
R. E. Tiedemann et al.
LEUKEMIA (2008)
Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6
Anja Mottok et al.
BLOOD (2007)
Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma
Jun-Ichi Tamaru et al.
LEUKEMIA & LYMPHOMA (2007)
Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma
I Wlodarska et al.
BLOOD (2003)
Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors
H Avet-Loiseau et al.
BLOOD (2001)
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood
FE van Leeuwen et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Rare occurrence of classical Hodgkin's disease as a T cell lymphoma
M Müschen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
